ilShinbiobase Co. Ltd (068330) — Cash Flow Reinvestment Rate
ilShinbiobase Co. Ltd (068330) has a Cash Flow Reinvestment Rate of 2.41x as of June 2026, reinvesting ₩1.03 Billion (capex ₩0.00 plus investments ₩1.03 Billion) from operating cash flow of ₩426.36 Million. See financial agility of ilShinbiobase Co. Ltd to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ilShinbiobase Co. Ltd Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for ilShinbiobase Co. Ltd across 12 annual periods. Explore debt repayment capacity of ilShinbiobase Co. Ltd to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for ilShinbiobase Co. Ltd (2014–2025)
Year-by-year capital reinvestment analysis for ilShinbiobase Co. Ltd. For the full cash flow conversion analysis, see cash flow conversion of ilShinbiobase Co. Ltd.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.90x | ₩4.73 Billion | ₩5.27 Billion | ₩20.64 Million | ▼ -20.7% |
| 2024 | 1.13x | ₩4.66 Billion | ₩4.12 Billion | ₩53.53 Million | ▲ +15.3% |
| 2023 | 0.98x | ₩5.81 Billion | ₩5.92 Billion | ₩262.17 Million | ▼ -68.2% |
| 2022 | 3.09x | ₩8.18 Billion | ₩2.65 Billion | ₩522.59 Million | ▲ +14888.1% |
| 2021 | 0.02x | ₩139.12 Million | ₩6.74 Billion | ₩139.12 Million | ▼ -89.6% |
| 2020 | 0.20x | ₩892.64 Million | ₩4.50 Billion | ₩892.64 Million | ▼ -76.9% |
| 2019 | 0.86x | ₩4.77 Billion | ₩5.55 Billion | ₩245.41 Million | ▲ +140.1% |
| 2018 | 0.36x | ₩1.75 Billion | ₩4.88 Billion | ₩385.81 Million | ▲ +0.9% |
| 2017 | 0.35x | ₩749.79 Million | ₩2.11 Billion | ₩407.59 Million | ▼ -83.8% |
| 2016 | 2.19x | ₩6.59 Billion | ₩3.01 Billion | ₩271.94 Million | ▲ +101.5% |
| 2015 | 1.09x | ₩293.89 Million | ₩270.22 Million | ₩99.39 Million | ▲ +2627.6% |
| 2014 | 0.04x | ₩132.61 Million | ₩3.33 Billion | ₩101.50 Million | — |